Sofia Attelind
Researcher at Department of Medical Sciences; Clinical pharmacogenomics and osteoporosis
- Telephone:
- +46 70 337 90 36
- E-mail:
- sofia.attelind@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 61
- Postal address:
- Akademiska sjukhuset, ingång 61
751 85 Uppsala
Publications
Recent publications
Pulmonary embolism after SARS-CoV-2 vaccination
Part of Vaccine: X, 2024
- DOI for Pulmonary embolism after SARS-CoV-2 vaccination
- Download full text (pdf) of Pulmonary embolism after SARS-CoV-2 vaccination
Identification of risk factors for adverse drug reactions in a pharmacovigilance database
Part of Pharmacoepidemiology and Drug Safety, 2024
Identification of risk factors for adverse drug reactions in a pharmacovigilance database
Part of Pharmacoepidemiology and Drug Safety, p. 1431-1438, 2023
- DOI for Identification of risk factors for adverse drug reactions in a pharmacovigilance database
- Download full text (pdf) of Identification of risk factors for adverse drug reactions in a pharmacovigilance database
Part of Frontiers in Genetics, 2022
- DOI for Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
- Download full text (pdf) of Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
All publications
Articles in journal
Pulmonary embolism after SARS-CoV-2 vaccination
Part of Vaccine: X, 2024
- DOI for Pulmonary embolism after SARS-CoV-2 vaccination
- Download full text (pdf) of Pulmonary embolism after SARS-CoV-2 vaccination
Identification of risk factors for adverse drug reactions in a pharmacovigilance database
Part of Pharmacoepidemiology and Drug Safety, 2024
Identification of risk factors for adverse drug reactions in a pharmacovigilance database
Part of Pharmacoepidemiology and Drug Safety, p. 1431-1438, 2023
- DOI for Identification of risk factors for adverse drug reactions in a pharmacovigilance database
- Download full text (pdf) of Identification of risk factors for adverse drug reactions in a pharmacovigilance database
Part of Frontiers in Genetics, 2022
- DOI for Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
- Download full text (pdf) of Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events